Medicare Enrolled

Dr. David Mobley, M.D.

Optician · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
18300 KATY FWY, Houston, TX 77094
8325228300
In practice since 2005 (20 years)
NPI: 1649272170 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Mobley from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mobley? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Mobley

Dr. David Mobley is an optician in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Mobley performed 1,436 Medicare services across 1,062 unique beneficiaries.

Between the years covered by Open Payments, Dr. Mobley received a total of $45,639 from 57 pharmaceutical and/or device companies across 361 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Mobley is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 41% volume in TX$ $45,639 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,436
Medicare services
Top 41% in TX for optician
1,062
Unique beneficiaries
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~72 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Office visit, established patient (20-29 min)823$59$212
Bladder ultrasound after voiding186$8$112
Drug injection, under skin or into muscle103$10$97
Office visit, established patient (30-39 min)60$93$314
New patient office visit (30-44 min)57$79$317
New patient office visit (45-59 min)56$103$483
Injection, amikacin sulfate, 100 mg55$1$4
Diagnostic exam of bladder and urethra using an endoscope34$181$1,081
Ultrasound scan of pelvic region through rectum22$108$498
Biopsy of prostate gland21$167$1,186
Complete laser vaporization of prostate including control of bleeding using an endoscope19$545$3,617
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$45,639
Total received (2018-2024)
Avg $6,520/year across 7 years
Top 6% in TX for optician
57
Companies
361
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$27,031 (59.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,567 (23.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$8,040 (17.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,584
2023
$9,843
2022
$1,476
2021
$390
2020
$3,622
2019
$8,303
2018
$20,421

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$27,136
EDAP TECHNOMED INC
$9,256
Boston Scientific Corporation
$1,787
PFIZER INC.
$1,128
Endo Pharmaceuticals Inc.
$899
Coloplast Corp
$778
Axonics, Inc.
$562
Myriad Genetic Laboratories, Inc.
$272
Janssen Biotech, Inc.
$255
COLOPLAST CORP
$240
Actelion Pharmaceuticals US, Inc.
$218
ConvaTec Inc.
$206
E.R. Squibb & Sons, L.L.C.
$192
ABBVIE INC.
$185
Merck Sharp & Dohme LLC
$154
AMAG Pharmaceuticals, Inc.
$143
BOSTON SCIENTIFIC CORPORATION
$126
Novo Nordisk Inc
$126
Dendreon Pharmaceuticals LLC
$119
Amarin Pharma Inc.
$118
NeoTract Inc.
$115
Antares Pharma, Inc.
$112
Paratek Pharmaceuticals, Inc.
$106
Ferring Pharmaceuticals Inc.
$94
Allergan, Inc.
$90
Avadel Specialty Pharmaceuticals, LLC
$90
180 Medical, Inc.
$87
Janssen Products, LP
$80
NxThera, Inc.
$74
Tolmar, Inc.
$72
ABC Home Medical Supply, Inc.
$64
Blue Earth Diagnostics Limited
$62
AbbVie, Inc.
$58
Endo USA, Inc.
$46
Ethicon US, LLC
$44
Allergan Inc.
$44
Egalet US Inc
$39
Amgen Inc.
$37
Retrophin, Inc.
$33
Hollister Incorporated
$32
Zyla Life Sciences
$31
Olympus America Inc.
$30
BIOTISSUE HOLDINGS INC.
$29
Janssen Pharmaceuticals, Inc
$29
DENTSPLY IH Inc.
$28
Myovant Sciences Inc.
$24
Medtronic, Inc.
$23
Alafair Biosciences, Inc.
$22
Merck Sharp & Dohme Corporation
$19
Medtronic USA, Inc.
$18
Travere Therapeutics, Inc.
$17
PROCEPT BioRobotics Corporation
$17
Sumitomo Pharma America, Inc.
$17
Acerus Pharmaceuticals Corporation
$16
C. R. Bard, Inc. & Subsidiaries
$14
BIOTISSUE HOLDINGS, INC.
$13
AKRIMAX PHARMACEUTICALS, LLC
$13
Top 3 companies account for 83.7% of total payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ALTIS · AMS · AMS 700 · AVEED · Altis · Androgel · AquaBeam Robotic System · Axonics · Axumin · BOTOX · BOTOX THERAPEUTIC · BRAC CDx · BRACAnalysis CDx · Bulkamid · CATHETER · CURE CATHETER · Coloplast TFL Drive · ECHELON ENDOPATH · EDEX · ELIGARD · ELIQUIS · ERLEADA · Erleada · GENERAL BPH · GENERAL KIDNEY STONE DISEASE · GENERAL - BPH · GENERAL BPH · GENERAL FEMALE SUI · GENTLECATH · General - Therapies · INLAY OPTIMA · INTERSTIM · INTRAROSA · Isiris aStent Removal Device · KEYTRUDA · LUPRON DEPOT · LoFric · Lupron · Lupron Depot · MIRABEGRON · MYRBETRIQ · Myrbetriq · NEOX · NOCDURNA · NUZYRA · Natesto · Noctiva · ORGOVYX · Olympus Laser Devices · Ozempic · PROLARIS · PROVENGE · Porges Coloplast · Prolaris · Prolia · Rezum · Rezum Generator · Rivfloza · SIGNIA · SOLYX · SPRIX · SpeediCath · Stendra · TACTRA · TESTOPEL · TLANDO · TOVIAZ · Thiola · Titan · UPTRAVI · UroLift · VESICARE · VISTASEAL Fibrin Sealant (Human) · VaPro · Vascepa · VersaWrap · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (59%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in optician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for optician in TX.

Equivalent to $3,178 per 100 Medicare services performed
Looking for a optician in Houston?
Compare opticians in the Houston area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Geographic Context

Opticians within 10 mi
480
Per 100K population
10.1
County median income
$73,104
Nearest hospital
HOUSTON METHODIST WEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Mobley is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 6%), with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Mobley experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Mobley performed 823 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mobley receive payments from pharmaceutical companies?
Yes. Dr. Mobley received a total of $45,639 from 57 companies across 361 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mobley's costs compare to other opticians in Houston?
Dr. Mobley's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mobley) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →